ArticleCardiovascular research2022

The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure.

Leila Rouhi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.